tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

DE:BTPC Stock Latest News

Active Biotech Wins Approval to Resume Expanded Tasquinimod Myelofibrosis Trial
Company AnnouncementsActive Biotech Wins Approval to Resume Expanded Tasquinimod Myelofibrosis Trial
1M ago
Active Biotech Updates Share Count After Completed Rights Issue
PremiumCompany Announcements
Active Biotech Updates Share Count After Completed Rights Issue
2M ago
Active Biotech Names Shareholder-Backed Nomination Committee Ahead of 2026 AGM
PremiumCompany Announcements
Active Biotech Names Shareholder-Backed Nomination Committee Ahead of 2026 AGM
2M ago
Active Biotech Secures Funding Through Successful Rights Issue
PremiumCompany Announcements
Active Biotech Secures Funding Through Successful Rights Issue
3M ago
Active Biotech Secures US Patent for Tasquinimod Formulation
PremiumCompany Announcements
Active Biotech Secures US Patent for Tasquinimod Formulation
4M ago
Active Biotech Launches Rights Issue to Fund Key Projects
PremiumCompany AnnouncementsActive Biotech Launches Rights Issue to Fund Key Projects
4M ago
Active Biotech’s Tasquinimod Shows Promise in Myelofibrosis Treatment
Premium
Company Announcements
Active Biotech’s Tasquinimod Shows Promise in Myelofibrosis Treatment
4M ago
Active Biotech Announces SEK 70 Million Rights Issue
Premium
Company Announcements
Active Biotech Announces SEK 70 Million Rights Issue
4M ago
Active Biotech AB Approves Share Capital Amendments and Rights Issue
PremiumCompany Announcements
Active Biotech AB Approves Share Capital Amendments and Rights Issue
4M ago
Active Biotech to Present Promising Tasquinimod Data at ASH 2025
PremiumCompany Announcements
Active Biotech to Present Promising Tasquinimod Data at ASH 2025
5M ago
Active Biotech Secures SEK 70 Million for Key Drug Developments
PremiumCompany Announcements
Active Biotech Secures SEK 70 Million for Key Drug Developments
5M ago
Active Biotech Announces Extraordinary General Meeting for Strategic Changes
PremiumCompany Announcements
Active Biotech Announces Extraordinary General Meeting for Strategic Changes
5M ago
Active Biotech Reports Positive Phase I Results for Laquinimod Eye Drops
PremiumCompany AnnouncementsActive Biotech Reports Positive Phase I Results for Laquinimod Eye Drops
6M ago
Active Biotech Updates on Laquinimod and Tasquinimod Development Programs
Premium
Company Announcements
Active Biotech Updates on Laquinimod and Tasquinimod Development Programs
9M ago
Active Biotech Highlights Positive LION Study Results for Laquinimod Eye Drops
Premium
Company Announcements
Active Biotech Highlights Positive LION Study Results for Laquinimod Eye Drops
9M ago
Active Biotech’s Tasquinimod Shows Promise in Multiple Myeloma Study
PremiumCompany Announcements
Active Biotech’s Tasquinimod Shows Promise in Multiple Myeloma Study
10M ago
Active Biotech AB’s Annual General Meeting Resolutions for 2025
PremiumCompany Announcements
Active Biotech AB’s Annual General Meeting Resolutions for 2025
10M ago
Active Biotech’s Tasquinimod Shows Promise in Multiple Myeloma Study
PremiumCompany Announcements
Active Biotech’s Tasquinimod Shows Promise in Multiple Myeloma Study
10M ago
Active Biotech Secures European Patent for Tasquinimod in Myelofibrosis
PremiumCompany Announcements
Active Biotech Secures European Patent for Tasquinimod in Myelofibrosis
10M ago
Active Biotech AB Announces 2025 Annual General Meeting
PremiumCompany AnnouncementsActive Biotech AB Announces 2025 Annual General Meeting
11M ago
Active Biotech Announces 2025 AGM and Board Re-elections
Premium
Company Announcements
Active Biotech Announces 2025 AGM and Board Re-elections
11M ago
Active Biotech AB Announces 2025 Annual General Meeting
Premium
Company Announcements
Active Biotech AB Announces 2025 Annual General Meeting
11M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >